海正生材：股东中石化资本累计减持公司股份203万股，减持计划已实施完毕

Group 1 - The core point of the article is that Sinopec Capital has completed a share reduction plan for Haizheng Biomaterials, reducing its stake to 5.32% of the total shares outstanding [1] - As of November 11, 2025, Sinopec Capital has reduced its holdings by 2,026,700 shares, which represents 1% of the total share capital of Haizheng Biomaterials [1] - Following the reduction, Sinopec Capital now holds 10,788,194 shares in Haizheng Biomaterials [1] Group 2 - Haizheng Biomaterials reported that its revenue composition for the year 2024 is heavily weighted towards the fiber manufacturing industry, accounting for 98.77% of total revenue [1] - The company's other business segments contribute only 1.23% to its overall revenue [1] - As of the latest report, Haizheng Biomaterials has a market capitalization of 2.7 billion yuan [2]